ID
16792
Beschrijving
Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline Glargine; ODM derived from: https://clinicaltrials.gov/show/NCT00518427
Link
https://clinicaltrials.gov/show/NCT00518427
Trefwoorden
Versies (1)
- 07-08-16 07-08-16 -
Geüploaded op
7 augustus 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Diabetes Type 2 NCT00518427
Eligibility Diabetes Type 2 NCT00518427
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI-1
- C0680251
Beschrijving
Autoimmune diabetes
Datatype
boolean
Alias
- UMLS CUI [1]
- C0205734
Beschrijving
Thiazolidinedione
Datatype
boolean
Alias
- UMLS CUI [1]
- C1257987
Beschrijving
Retinopathy with surgical treatment
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0011884
- UMLS CUI [1,2]
- C0543467
Beschrijving
Drug abuse
Datatype
boolean
Alias
- UMLS CUI [1]
- C0038586
Beschrijving
hypersensitivity to insulin glagine excipients
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C0907402
Beschrijving
Study Subject Participation Status
Datatype
boolean
Alias
- UMLS CUI [1]
- C2348568
Similar models
Eligibility Diabetes Type 2 NCT00518427
- StudyEvent: Eligibility
C0860160 (UMLS CUI [2,1])
C0021658 (UMLS CUI [2,2])
C0860160 (UMLS CUI [3,1])
C0359086 (UMLS CUI [3,2])
C0178602 (UMLS CUI [1,2])
C0017642 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0061323 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0025598 (UMLS CUI [4,1])
C0178602 (UMLS CUI [4,2])
C0050393 (UMLS CUI [5,1])
C0178602 (UMLS CUI [5,2])
C0281588 (UMLS CUI [1,2])
C0543467 (UMLS CUI [1,2])
C0907402 (UMLS CUI [1,2])